• Comment: Purely promotional. Greenman (talk) 15:11, 7 June 2023 (UTC)

Biotricity is an American medical technology company headquartered in Redwood City, California.bBiotricity is known for being “a remote patient monitoring company that’s entered the wearable medical technology market from a cardiac angle.”[1] Its cardiac monitoring products are the Bioflux and the Bioheart, which earned a spot on TIME magazine’s Best Inventions of 2022 list.[2] Fast Company named it one of the Top 50 Most Innovative Companies and the Most Innovative Medical Device Company.[3]

Biotricity was founded on January 1, 2014, by Dr. Waqaas Al-Siddiq, Ph.D. to deliver remote biometric monitoring solutions to the medical and consumer markets.[4] The company became publicly traded on February 2, 2016, and had its initial public offering on August 30, 2021, when it registered under the ticker NASDAQ: BTCY.[5] As of 2023, the company has seen recent accelerating revenue gains thanks to an increase in sales of its cardiac monitoring devices and recurring subscription-based services.[6] In April 2023, Biotricty reported a record $13 million annualized revenue run rate.[7]



References edit

  1. ^ "Biotricity CEO: Why a Clear Path to Revenue is the Key to Entering New Markets | INN".
  2. ^ "Biotricity Bioheart: The 200 Best Inventions of 2022". 10 November 2022.
  3. ^ "Waqaas Al-siddiq - Forbes Business Council". Forbes.
  4. ^ https://www.crunchbase.com/organization/biotricity
  5. ^ https://www.crunchbase.com/organization/biotricity/company_financials
  6. ^ "Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth".
  7. ^ "Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth".